SCHEMBL4908882

SCHEMBL4908882

Cc1ccc(S(=O)(=O)NCCc2ccc(OCC(F)(F)C(F)F)cc2)cc1C(=O)O

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.51
AKR1C3 P42330 2/20 0.47
TBXA2R P21731 1/20 0.46
TBXAS1 P24557 1/20 0.46
POLB P06746 1/20 0.45
TP53 P04637 2/20 0.45
ALDH1A1 P00352 3/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
MAPT P10636 3/20 0.44
RECQL P46063 1/20 0.44
SGMS1 Q86VZ5 4/20 0.43
CA12 O43570 1/20 0.43
CA1 P00915 1/20 0.43
CA2 P00918 1/20 0.43
ADRB2 P07550 1/20 0.43
ADRB1 P08588 1/20 0.43
CA9 Q16790 1/20 0.43
PKM P14618 1/20 0.43
MAPK1 P28482 1/20 0.43
HTT P42858 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4902429 0.92 ALDH1A1 (0.46) LMNAAKR1C3TBXA2RTBXAS1POLB
SCHEMBL4894377 0.90 TBXA2R (0.45) LMNAAKR1C3TBXA2RTBXAS1POLB
SCHEMBL4909044 0.90 AKR1C3 (0.46) AKR1C3TBXA2RTBXAS1POLBTP53
SCHEMBL4905297 0.84 ADAMTS4 (0.50) LMNAAKR1C3TBXA2RTBXAS1POLB
SCHEMBL4907127 0.83 LMNA (0.51) LMNAAKR1C3TBXA2RTBXAS1POLB
SCHEMBL4906637 0.83 LMNA (0.51) LMNAAKR1C3TBXA2RTBXAS1POLB
SCHEMBL4905595 0.83 ALDH1A1 (0.45) LMNAAKR1C3TBXA2RTBXAS1POLB
SCHEMBL4905345 0.83 ALDH1A1 (0.42) AKR1C3TBXA2RTBXAS1POLBTP53
SCHEMBL4894652 0.82 LMNA (0.50) LMNAAKR1C3POLBTP53ALDH1A1
SCHEMBL4897468 0.82 ALDH1A1 (0.55) LMNAAKR1C3TBXA2RTBXAS1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD LMNA 319/4885AKR1C3 1645/4885TBXA2R 330/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD LMNA 319/4885AKR1C3 1645/4885TBXA2R 330/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.